Severe influenza infection in a chronic hepatitis C carrier: Failure of protective serum HI antibodies after IM vaccination

Journal of Clinical Virology

Volumn 29, Issue 1, 2004, Pages 23-26

  Greenbaum, E ^a   Nir Paz, R ^b   Linton, D M ^b   Ben Hur, T ^b   Meirovitz, A ^b   Zakay Rones, Z ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Hepatitis C virus (HCV); Immunocompromised; Influenza infection; Vaccination

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; HUMORAL ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A; LABORATORY TEST; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS STRAIN;

EID: 0348111361     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00194-X     Document Type: Article

References (14)

1. Bridges C.B., Fukuda K., Uyeki T.M., Cox N.J., Singleton J.A. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 51:2002;1-31.
2. Clements M.L. Influenza vaccines. Biotechnology. 20:1992;129-150.
3. Cox N.J., Subbarao K. Influenza. Lancet. 354:1999;1277-1282.
4. Frankova V., Jirasek A., Tumova B. Type A influenza: postmortem virus isolations from different organs in human lethal cases. Arch. Virol. 53:1977;265-268.
5. Gordon A.C., Edgar J.D., Finch R.G. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J. Infect. 36:1998;229-230.
6. Klimov A.I., Rocha E., Hayden F.G., Shult P.A., Roumillat L.F., Cox N.J. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J. Infect. Dis. 172:1995;1352-1355.
7. Mader R., Narendran A., Lewtas J., Bykerk V., Goodman R.C., Dickson J.R.et al. Systemic vasculitis following influenza vaccination - report of three cases and literature review. J. Rheumatol. 20:1993;1429-1431.
8. 2) virus in a persistently infected immunocompromised host is similar to that occurring in the community. Clin. Infect. Dis. 29:1999;456-458.
9. McMurray R.W., Elbourne K. Hepatitis C virus infection and autoimmunity. Semin. Arthritis Rheum. 26:1997;689-701.
10. Morishima T., Togashi T., Yokota S., Okuno Y., Miyazaki C., Tashiro M.et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin. Infect. Dis. 35:2002;512-517.
11. Pyhala R., Kumpulainen V., Alanko S., Forsten T. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Vaccine. 12:1994;947-952.
12. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1996;1432-1440.
13. Ronni T., Matikainen S., Sareneva T., Melen K., Pirhonen J., Keskinen P.et al. Regulation of IFN-alpha/beta, M × A, 2′,5′- oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J. Immunol. 158:1997;2363-2374.
14. 1 virus. Lancet. 351:1998;467-471.